No profile data available.
Roivant Sciences Ltd. (ROIV) is a healthcare company in the pharmaceutical administration systems industry, based in London, United Kingdom, with about 721 full-time employees.
It reported revenue of $8.26 million for fiscal year 2026, down 71.6% from fiscal year 2025, and net income of -$299.77 million. In Q1 2027 (the quarter ended June 30, 2026) revenue was $1.44 million, down 33.5% from a year before. Its market capitalization was $25.60 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
Roivant Sciences reported $8.26 million in revenue for fiscal year 2026, down 71.6% from $29.05 million in fiscal year 2025. In Q1 2027 revenue was $1.44 million.
$25.60 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (pharmaceutical administration systems) include Rani Therapeutics Holdings, Inc. (RANI), Lexaria Bioscience Corp. (LEXX), Xenetic Biosciences, Inc. (XBIO), Skinvisible, Inc. (SKVI).